[Nontuberculous mycobacterial pulmonary disease]

Area of Science:

• Microbiology
• Infectious Diseases
• Pulmonology

Background:

• Nontuberculous mycobacteria (NTM) are diverse, drug-resistant bacteria with increasing clinical significance.
• Susceptible individuals, particularly those with chronic respiratory diseases like COPD, are at risk of NTM infection.
• NTM pulmonary disease (NTM-PD) shares symptoms with other lung conditions, often leading to delayed diagnosis.

Purpose of the Study:

• To highlight the growing global impact of NTM infections.
• To emphasize the diagnostic and therapeutic challenges associated with NTM-PD.
• To underscore the need for specialized management of NTM-PD.

Main Methods:

• Review of current data on NTM epidemiology and clinical significance.
• Analysis of diagnostic criteria for NTM-PD (clinical, radiological, microbiological).
• Discussion of treatment complexities, including antimicrobial regimens and adverse event monitoring.

Main Results:

• NTM infections are increasing worldwide and pose a risk to vulnerable populations.
• Diagnosis of NTM-PD is frequently delayed due to overlapping symptoms with other respiratory diseases.
• Treatment of NTM-PD is demanding, requiring tailored, often lengthy, and potentially toxic regimens.

Conclusions:

• NTM-PD requires careful diagnosis and management due to its complexity and potential for treatment failure.
• Patient and pathogen factors are crucial in selecting appropriate antimicrobial combinations.
• An interdisciplinary approach and specialist referral are recommended for severe or refractory NTM-PD cases.